|
Volumn 471, Issue 7339, 2011, Pages
|
Designing smarter cancer prevention trials.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZASTEROID;
DUTASTERIDE;
TUMOR MARKER;
ANIMAL;
ARTICLE;
BLOOD;
CLINICAL TRIAL (TOPIC);
DISEASE MODEL;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HEALTH;
HUMAN;
LEGAL ASPECT;
MALE;
METHODOLOGY;
NEOPLASM;
PROSTATE TUMOR;
REPRODUCIBILITY;
RISK ASSESSMENT;
UNITED STATES;
ANIMALS;
AZASTEROIDS;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
DRUG APPROVAL;
HEALTH;
HUMANS;
MALE;
NEOPLASMS;
PROSTATIC NEOPLASMS;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
TUMOR MARKERS, BIOLOGICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 79955697853
PISSN: None
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/471S20a Document Type: Article |
Times cited : (2)
|
References (0)
|